Epithelial Cell Dynamics in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) arises from a breakdown of the tightly regulated cycle of epithelial cell proliferation, differentiation, migration and shedding that maintains the intestinal barrier. In health, epithelial stem cells in the crypt base divide and give rise to enterocytes, goblet cells and enteroendocrine cells, which migrate along the villus before undergoing apoptosis and extrusion at its tip. This coordinated turnover preserves barrier integrity against luminal microbes and toxins while permitting nutrient absorption. In IBD, genetic susceptibilities and environmental triggers converge to disrupt cell signalling, tight junctions and antimicrobial defences. Excessive cytokine-driven apoptosis, impaired restitution of denuded areas and altered epithelial-microbiota cross-talk result in increased permeability, mucosal ulceration and chronic inflammation. Recent work has emphasised the dual roles of inflammatory mediators—notably tumour necrosis factor and prostaglandins—in both epithelial injury and repair, as well as the importance of intracellular pathways (such as NF-κB, RIPK and PI3K–Akt axes) that govern the balance between survival and death. Understanding these dynamics informs therapeutic strategies aimed at restoring barrier function, re-establishing immune tolerance and reconditioning the microbial ecosystem.

Research from Nature Portfolio

Recent studies have elucidated how endogenous lipid mediators protect the mucosa by enhancing pro-survival signalling within epithelial cells. One key finding demonstrates that cyclooxygenase-1-derived prostaglandin E₂ fosters mucosal healing in experimental colitis through upregulation of β-arrestin1 and subsequent activation of the PI3K–Akt pathway. In models of chemical injury, exogenous PGE₂ restored tight junction integrity and attenuated diarrhoeal symptoms, while loss of β-arrestin1 amplified tissue damage and inflammatory cell influx. This work highlights a therapeutic axis in which selective modulation of COX-1/PGE₂ signalling can strengthen epithelial resilience and accelerate restitution in IBD.

Epithelial Cell Dynamics in Inflammatory Bowel Disease publication trend

The graph below shows the total number of articles in epithelial cell dynamics in inflammatory bowel disease across all publications each year (not limited to Nature Index journals).

Technical terms

Intestinal epithelial cell (IEC): A single layer of specialised cells lining the gut that mediates nutrient absorption and barrier function.

Apoptosis: Programmed cell death essential for removing aged or damaged cells without provoking inflammation.

Tight junction: Protein complexes between epithelial cells that seal intercellular spaces to prevent uncontrolled permeability.

Prostaglandin E₂ (PGE₂): A bioactive lipid mediator produced by cyclooxygenase enzymes that regulates inflammation and tissue repair.

β-arrestin1: A scaffold protein that couples G-protein-coupled receptors to intracellular pathways such as PI3K–Akt, promoting cell survival.

Receptor-interacting protein kinase (RIPK): Enzymes that orchestrate signalling cascades leading to either cell survival, apoptosis or necroptosis in epithelial cells.

References

1. Ring1a protects against colitis through regulating mucosal immune system and colonic microbial ecology. Gut Microbes (2023).
2. Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut. Frontiers in Immunology (2019).
3. Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells. Science Advances (2021).
4. COX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis. Scientific Reports (2017).